Medscape2h
GLP-1 Reduces Recurrent Ischemic Stroke in Type 2 Diabetes
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Weight Loss Revolution Part 1: The pros and cons of weight loss drugs
Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.
All-you-can’t-eat: GLP-1 drugs pose new challenges for restaurants, but how do they work?
When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...
Health and Me on MSN1d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney Disease
A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
Morningstar7d
ACCP Position Statement: "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists"
ACCP is a non-profit association providing accredited Continuing Education, publications and career-enhancing opportunities to clinical pharmacology healthcare professionals. We sell different ...
Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
Modern Healthcare9d
Digital health companies pitch employers on cutting GLP-1 costs
Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...
HealthDay on MSN5d
New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...